Human papillomavirus (HPV) vaccination uptake (initiation and completion): factors associated with uptake of the human papillomavirus (HPV) vaccine among young people living with HIV in Uganda
Scovia Nalugo Mbalinda, Aggrey Semeere, Derrick Amooti Lusota, Jean Hunleth, Michelle Silver, Dan Kabonge Kaye, Miriam Nakalembe · 2026
Read Human papillomavirus (HPV) vaccination uptake (initiation and completion): factors associated with uptake of the human papillomavirus (HPV) vaccine among young people living with HIV in Uganda by Scovia Nalugo Mbalinda, Aggrey Semeere, Derrick Amooti Lusota, Jean Hunleth, Michelle Silver, Dan Kabonge Kaye, Miriam Nakalembe (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13576116.txt.
Description
Scovia Nalugo Mbalinda leads a 2026 study of HPV vaccine uptake among young Ugandans living with HIV. HPV infection and its diseases hit this group hard, and the vaccine can prevent much of that harm. Uganda's uptake, though, has stayed patchy, with many starting the doses yet few finishing them.
The survey covered 274 clinic patients aged 15 to 24 in 2024, and their ages averaged 20.3 years. Starting the vaccine was reported by 68.2 percent, while only 24.1 percent had completed two or more doses. Starting linked strongly to school teaching about the vaccine, living within five kilometres of the clinic, vaccine stock on site, and younger age. Completion linked to the older age band. The authors urge priority for this group and fixes aimed at finishing the course.
Catalog record
| CREATOR | Scovia Nalugo Mbalinda, Aggrey Semeere, Derrick Amooti Lusota, Jean Hunleth, Michelle Silver, Dan Kabonge Kaye, Miriam Nakalembe |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47548 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |